POSITRON EMISSION TOMOGRAPHY SCANNERS MARKET ANALYSIS

Positron Emission Tomography Scanners Market Size and Trends

Global positron emission tomography (PET) scanners market is estimated to be valued at USD 2.41 Bn in 2024 and is expected to reach USD 3.52 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2024 to 2031.

To learn more about this report, request sample copy

Global positron emission tomography (PET) scanners market is expected to witness considerable growth during the forecast period due to increasing prevalence of chronic diseases such as cancer and cardiovascular diseases. Continuous technological advancements in the development and quality of PET scanners, in order to provide high resolution images, can also drive the market growth during the forecast period. Adoption of hybrid PET scanners integrated with CT or MRI can also drive the market growth. However, high cost of PET scans and non-availability of PET scanners in certain underdeveloped regions can hamper the market growth.

Rising Prevalence of Cancer and Cardiovascular Diseases

Rising burden of cancer and cardiovascular diseases can drive the market growth. As per the data from WHO, cancer accounted for nearly 10 million deaths in 2020 worldwide.  Key factors contributing to cancer incidence include growing prevalence of risk factors such as smoking, obesity, physical inactivity and changing lifestyle habits. Cardiovascular diseases remain the top cause of mortality with over 17 million deaths reported annually, as per WHO. Aging population worldwide and increasing life expectancy has further contributed to escalating cases of cancer and heart conditions which often require medical imaging for accurate diagnosis and staging of the disease. PET scanning has emerged as an important imaging modality, owing to its high sensitivity and ability to detect even small malignant tumors or early signs of heart diseases. Its utilization continues to grow rapidly, especially in developed nations for cancer screening and detection of recurrence. This growing disease burden as well as emphasis on early detection can boost demand for PET scanners.

Rising Acceptance of PET-CT Scanners in Oncology Settings

PET scanning technology has witnessed substantial evolution over the past decades. The emergence of hybrid PET-CT imaging, where both anatomical and metabolic information can be obtained from a single scan session, has remarkably increased the clinical applications of PET imaging. PET-CT is now considered the standard of care for accurate cancer staging, treatment planning, therapy response assessment and detecting relapse or metastasis. Its high diagnostic value in oncology compared to other conventional imaging modalities like CT, MRI or ultrasound has boosted installation of PET-CT systems globally. Moreover, oncologists are relying more on PET-CT for tumor imaging considering its ability to detect cancer recurrence earlier than other tests. Reimbursement policies in several countries now cover PET-CT for various cancer indications. Therefore, expanding clinical applications and growing insurance coverage for PET-CT scans in cancer management across hospitals and diagnostic centers worldwide can boost demand for PET scanners. Manufacturers are also introducing new generation PET-CT devices with faster acquisition time, enhanced resolution and throughput, and this boosts their adoption rate in clinical oncology practice.